Waters Corporation (WAT) Stock Analysis

WAT

Market Closed

Waters Corporation

NYSEHealthcare Medical - Diagnostics & Research

7.60K employees

CEO: Udit Batra

Founded: 1995

$355.44

+$0.00(+NaN%)

Market Cap

23.17B

Beta

1.20

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

WAT Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for WAT built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Strong Sell

Pass %

42.86%

Score

3/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$235.79

AI Price Target

Machine learning • Price prediction

$358.24

Market Sentiment

News & social media analysis

0.03

Value Investor Price

Classic value analysis

$0.00

Financial Health

Bankruptcy risk assessment

1.91

Quality Score

Financial strength rating

3.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting WAT investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

60.00% Good

Conditions Met

24.00/40.00

Due Diligence Score

60.00%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Fail
	Fail
	Pass
	Fail
	Pass

Showing 1 to 6 of 46 conditions

WAT